Brianne Dressen

J&J is an adenoviral vector vaccine. So it's a very similar technology. Yeah.

J&J is an adenoviral vector vaccine. So it's a very similar technology. Yeah.

Yeah, so AstraZeneca is an Oxford product. So it was the golden child in the UK. And the UK, at the very beginning of the vaccine rollout, they were telling the public, don't get the mRNA products. Just hang on for a couple more weeks. AstraZeneca is coming. This is the superior product of the UK.

Yeah, so AstraZeneca is an Oxford product. So it was the golden child in the UK. And the UK, at the very beginning of the vaccine rollout, they were telling the public, don't get the mRNA products. Just hang on for a couple more weeks. AstraZeneca is coming. This is the superior product of the UK.

And then in the US, they had the golden children, which was Pfizer and Moderna, the new novel mRNA technology.

And then in the US, they had the golden children, which was Pfizer and Moderna, the new novel mRNA technology.

These were all neuroimmune conditions. So they checked all of us with the similar testing. They checked the coagulation of our blood. They checked the MRIs, which just like everybody else, the MRIs looked fine. But that's when they really started looking into dysautonomia and POTS, small fiber neuropathy, EMGs with a large fiber neuropathy decay.

These were all neuroimmune conditions. So they checked all of us with the similar testing. They checked the coagulation of our blood. They checked the MRIs, which just like everybody else, the MRIs looked fine. But that's when they really started looking into dysautonomia and POTS, small fiber neuropathy, EMGs with a large fiber neuropathy decay.

And that's one thing that we've learned through our own research is the significant overlap between long COVID and post-vax syndrome. They look near identical, but there is a signature. And people that are suffering with post-vaccine adverse events really do have a higher likelihood of having these longer term neurological nerve damage type syndromes.

And that's one thing that we've learned through our own research is the significant overlap between long COVID and post-vax syndrome. They look near identical, but there is a signature. And people that are suffering with post-vaccine adverse events really do have a higher likelihood of having these longer term neurological nerve damage type syndromes.

I do. Yeah. My EMG came back positive on my left leg.

I do. Yeah. My EMG came back positive on my left leg.

It was interesting. They couldn't quite identify it early on. And because of the political dynamic going on in the United States in the summer of 2021, they actually shut down the study in the middle of it. So they were following up with every single participant weekly saying, hey, what are your symptoms doing? We've got some more updates on these tests that we've been waiting on.

It was interesting. They couldn't quite identify it early on. And because of the political dynamic going on in the United States in the summer of 2021, they actually shut down the study in the middle of it. So they were following up with every single participant weekly saying, hey, what are your symptoms doing? We've got some more updates on these tests that we've been waiting on.

They were really engaging with the patients in a You know, in a way that you would expect the government to be doing with a new novel set of diseases, right? But then, of course, OSHA mandates happened. And literally within days, our follow-up appointments to the NIH were canceled. Even our flights were canceled to go out there again. And all of a sudden, it was radio silence. So...

They were really engaging with the patients in a You know, in a way that you would expect the government to be doing with a new novel set of diseases, right? But then, of course, OSHA mandates happened. And literally within days, our follow-up appointments to the NIH were canceled. Even our flights were canceled to go out there again. And all of a sudden, it was radio silence. So...

Funny you ask. The FDA, we plugged in with them at the end of summer of 2021. At this time, it was Peter Marks, head of biologics at the FDA. We had several meetings with him, coordinating with him to discuss why they're not following the rest of the world in communicating these adverse events as they emerge to the American public, as we saw in Germany and Denmark earlier.

Funny you ask. The FDA, we plugged in with them at the end of summer of 2021. At this time, it was Peter Marks, head of biologics at the FDA. We had several meetings with him, coordinating with him to discuss why they're not following the rest of the world in communicating these adverse events as they emerge to the American public, as we saw in Germany and Denmark earlier.

They were doing something different, right? They gave us injured people that were advocating for other injured people. They gave us a long list of things that we should be doing to help them do their jobs. They asked us for all of the terms of neuropathy that we had identified in their VAERS system. They also did acknowledge to us that small fiber neuropathy is happening after COVID vaccination.

They were doing something different, right? They gave us injured people that were advocating for other injured people. They gave us a long list of things that we should be doing to help them do their jobs. They asked us for all of the terms of neuropathy that we had identified in their VAERS system. They also did acknowledge to us that small fiber neuropathy is happening after COVID vaccination.